{
  "ptid_time": "024_S_4905_2012-08-16",
  "img_path": "/data/qiuhui/data/adni/images/024_S_4905/2012-08-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 30,697 mm³, 9.4% above the reference mean. With a Z-score of 0.21 (58.5th percentile), this represents normal volume ; hippocampal volume measures 5,980 mm³, 15.9% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy; whole brain volume measures 971,114 mm³, 0.4% below the reference mean. With a Z-score of -0.05 (48.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,307 mm³, 37.2% below the reference mean. With a Z-score of -2.28 (1.1th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,802 mm³, 7.1% below the reference mean. With a Z-score of -0.65 (25.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,480 mm³, 19.2% below the reference mean. With a Z-score of -1.67 (4.7th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 72.7 years. Gender is Female. Education: 12 years. Handedness: Left. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 26.0. MoCA: 19.0. Logical Memory: 5.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.66 SUVR (profound elevated); Amyloid beta: 568.80 pg/mL (mild reduced); Total tau: 430.10 pg/mL (significant elevated); Phosphorylated tau: 46.04 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex and moderate atrophy in the middle temporal gyrus, along with mild hippocampal atrophy—all regions heavily implicated in Alzheimer's disease. The CSF biomarkers (elevated T-tau, P-tau, and AV45 with reduced Aβ) strongly support Alzheimer's pathology, while the cognitive scores (MMSE 26, MoCA 19) indicate mild but measurable impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease** (or **Prodromal Alzheimer’s disease** if using research criteria). The cognitive decline is not severe enough for dementia, but biomarker and structural changes align with early AD.  \n\n**Confidence:** **High** (biomarkers and imaging strongly support AD pathology, and cognitive scores are consistent with MCI).  \n\n*Note: If functional impairment in daily activities is present, this could cross the threshold for **dementia due to Alzheimer’s disease**, but the MMSE 26 suggests preserved function.*",
  "timestamp": "2025-07-26T03:22:37.088445"
}